The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 28, 2020
Filed:
Mar. 21, 2019
Applicant:
21c Bio, Paris, FR;
Inventor:
Daniel Zagury, Paris, FR;
Assignee:
21C Bio, Paris, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C12N 15/85 (2006.01); A61K 48/00 (2006.01); C07K 14/47 (2006.01); C07K 14/535 (2006.01); A61K 39/12 (2006.01); A61P 31/18 (2006.01); C12N 15/113 (2010.01); C12N 15/86 (2006.01); C07K 14/16 (2006.01); A61K 39/09 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 39/09 (2013.01); A61P 31/18 (2018.01); C07K 14/162 (2013.01); C12N 7/00 (2013.01); C12N 15/1132 (2013.01); C12N 15/86 (2013.01); A61K 2039/522 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/53 (2013.01);
Abstract
A novel method for preventing or treating an infectious disease in a subject in need thereof. In particular the method includes the administration of a combination, pharmaceutical combination, medicament or kit-of-parts having a first part including a CD8 vaccine specific for at least one infectious disease-related antigen, a second part including an agent neutralizing circulating alpha interferon and/or an agent blocking interferon alpha signaling, and/or a third part including a type III interferon and/or an agent stimulating the production of type III interferon.